Kranus Health

What Kranus Health does

Kranus Health GmbH is a Munich-based digital therapeutics company founded in 2020 that develops certified medical device applications for urological and uro-oncological conditions. Its product portfolio comprises Kranus Edera (erectile dysfunction), Kranus Lutera (lower urinary tract symptoms and benign prostatic hyperplasia), Kranus Mictera (female urinary incontinence), and an emerging uro-oncology line for prostate cancer. Each application is a 90-day prescribed therapy program combining multi-modal interventions — cardiovascular training, pelvic floor exercises, and psychological support — and is delivered as native iOS and Android apps built on Google Cloud Platform with T-Systems sovereign cloud infrastructure and FHIR-based data interoperability.

The company monetizes primarily through Germany's DiGA (Digitale Gesundheitsanwendungen) framework, in which the product is listed by BfArM under § 139e SGB V, prescribed by urologists, general practitioners, and physiotherapists, and reimbursed directly by statutory health insurers (GKV) via a Freischaltcode activation code. A secondary self-pay channel serves private patients. Go-to-market combines physician-led prescription, CME-accredited webinars, paid digital advertising, and content marketing anchored by a urology knowledge hub. The platform is certified to EU MDR medical device standards, ISO 27001, GDPR, and French HDS hosting requirements.

Kranus Health has raised more than $20 million across multiple funding rounds since 2020, most recently a March 2024 Series A extension led by CapHorn and Future Positive Capital to fund European and US expansion. The company operates legal entities in Germany and France, with planned US market entry and ongoing investment in prostate cancer therapies. The two co-founders — Jens Nörtershäuser (CEO) and Nikolay Dimolarov (CTO) — lead an expanded management team that includes a Chief Commercial Officer and Chief Scientific Officer.

Name

Kranus Health

Legal name

Kranus Health GmbH

Website

https://kranushealth.com

Company type

Private

Founded year

2020

Operating status

Operating

Headcount range

51–100 employees

Short description

Kranus Health is a Munich-based digital therapeutics company developing DiGA-certified mobile applications for urological conditions including erectile dysfunction, BPH, and female incontinence, distributed via physician prescription and German statutory health insurance reimbursement across Germany, France, and the US.

Ownership category

akta.pro rank

Product category

Digital Therapeutics (DiGA)

NAICS

Software Publishers (5132), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000), Services-Prepackaged Software (7372)

akta.pro primary industry

Urology Telemedicine Platforms (HLALAGAN)

akta.pro secondary industries

Prescription Digital Therapeutics (PDT) (HLACANAB), Sexual & Pelvic Health Telehealth (STI care, pelvic pain, endometriosis/PCOS support) (HLALAHAJ)

Keywords

• Digital therapeutics
• Urology digital health
• Men's health apps
• Medical device software
• Pelvic floor therapy

Headquarters

HQ city

Munich

HQ country

Germany

HQ region

Europe

Offices1 record

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. DiGA Reimbursement (Statutory Health Insurance): Kranus Health generates revenue through Germany's DiGA (Digitale Gesundheitsanwendungen) pathway. Patients with statutory health insurance (GKV) receive the therapy free of charge via a Freischaltcode (activation code) prescribed by a physician and dispensed by the health insurer. The company bills the statutory insurer directly on a per-patient, per-indication basis. This is the primary revenue channel in Germany.
2. Self-Pay / Private Patient Revenue: Private patients (private Krankenversicherung or self-paying individuals) are served through direct self-pay pricing, representing a secondary revenue stream outside the DiGA reimbursement framework.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels8 records

Core offering

Kranus Health develops prescription digital therapeutics (DiGA) for urological conditions, delivered as clinically validated mobile applications. The product portfolio addresses erectile dysfunction (Kranus Edera), benign prostatic hyperplasia and voiding dysfunction (Kranus Lutera), female urinary incontinence (Kranus Mictera), and a digital companion service for uro-oncology patients. Applications are prescribed by physicians, reimbursed by German statutory health insurers through the DiGA framework, and built on FHIR-based, GCP-certified infrastructure with sovereign cloud hosting.

Product overview

Kranus Health is a Munich-based digital health company offering virtual urology care through a portfolio of digital therapeutic applications. The company operates a platform-plus-products model consisting of three core products: Kranus Edera for erectile dysfunction, Kranus Lutera for voiding dysfunction/LUTS, and Kranus Mictera for female urinary incontinence. The company is expanding into uro-oncology services for prostate cancer treatment. Products are prescribed by healthcare professionals and delivered as 90-day therapy programs through iOS and Android applications, with data interoperability via FHIR exports and electronic patient record integration.

Differentiator

Problem solved

Functional benefit

Brands

• Kranus Edera: Digital health application for the non-medication treatment of erectile dysfunction, including cardiovascular training, pelvic floor exercises, and psychological support/sex therapy.
• Kranus Lutera
• Kranus Mictera

Products and services

• Kranus Edera Prescription digital therapeutic mobile application for first-line conservative treatment of erectile dysfunction in adult male patients, prescribed by physicians and reimbursed by German statutory health insurers.
• Kranus Lutera Prescription digital therapeutic mobile application for conservative management of benign prostatic hyperplasia (BPH) and associated voiding dysfunction in adult male patients, prescribed by urologists and reimbursed through DiGA.
• Kranus Mictera Prescription digital therapeutic mobile application for conservative treatment of female urinary incontinence, including pelvic floor training, prescribed by physicians and reimbursed through DiGA.
• Kranus Uro-Oncology Digital companion service for uro-oncology patients, particularly those with prostate cancer, providing continuous digital support, education, and care pathway reinforcement between clinical visits.

Quantifiable outcome

• Clinically supported reduction in erectile dysfunction symptoms through multi-modal digital therapeutic program (specific percentage not publicly quantified in available sources)
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration4 records

Feature6 records

Partnerships

Two partnerships are on record, tiered core.

• T-SystemscoreTechnology or Integration · 1 January 2024T-Systems provides sovereign cloud infrastructure for Kranus Health, enabling secure deployment and operation of the company's digital therapeutic platform in compliance with German and European data sovereignty requirements. This partnership supports the company's data security architecture and DiGA compliance requirements.
• Google Cloud Platform (GCP)coreTechnology or IntegrationGoogle Cloud Platform serves as the primary cloud infrastructure backbone for Kranus Health's digital therapeutic applications, providing compute, storage, and data analytics capabilities for the iOS and Android mobile platforms.

Scale indicators5 records

Recent moves7 records

Expansion highlights6 records

Direct peers

• GAIA AG: Hamburg-based pioneer in German digital therapeutics (DiGA) with multiple listed products in mental health and neurology. Directly comparable as a DiGA-listed prescription digital therapeutic company operating under the same BfArM framework with statutory insurance reimbursement.
• HelloBetter: Berlin-based digital therapeutics company with multiple DiGA-listed products in mental health (depression, anxiety, insomnia). Comparable as a German DiGA pure-play selling prescribed digital therapies reimbursed by statutory health insurers via the same Freischaltcode pathway.
• Selfapy: Berlin-based DiGA-listed digital therapeutic for mental health conditions. Closely comparable to Kranus as a German DTx company operating in the same regulatory, reimbursement, and physician-prescription paradigm.
• Oviva: European digital health company offering DiGA-listed digital therapeutics for obesity, diabetes, and related metabolic conditions. Comparable as a multi-country European DTx operator navigating similar DiGA and adjacent reimbursement frameworks.

Emerging players

• MIKA Health: Berlin-based digital health company developing a digital companion for cancer patients with DiGA-listed products. Comparable as a Germany-based prescription digital therapeutic company operating in the same DiGA reimbursement pathway, with overlap in Kranus's planned uro-oncology expansion.
• Akili Interactive: US prescription digital therapeutic company with FDA-cleared SaMD products (EndeavorRx). Comparable as a PDT platform company pursuing regulatory clearance and prescription-driven commercial models — a useful strategic parallel for Kranus's planned US SaMD path.

Broad incumbents

• Hims & Hers Health: US-listed consumer telehealth and digital health platform with significant men's health and ED-treatment offerings. Comparable as a player in men's health/urology with digital prescription delivery, though operating on a direct-to-consumer model rather than insurer-reimbursed DTx.
• Ro: US direct-to-patient telehealth and pharmacy platform offering ED treatment, men's health, and other chronic-condition digital care. Comparable as a men's-health digital platform competing for the same patient demand, but operating a US consumer model rather than DiGA-style reimbursement.
• BetterHelp (Teladoc Health): Largest direct-to-consumer teletherapy platform, part of Teladoc Health. Comparable as a scaled digital health subscription business treating sensitive conditions via mobile apps, though in mental health rather than urology.

Regional players

• Doctolib: France/Germany-headquartered telehealth and practice-management platform used by a majority of physicians in those markets. Comparable as critical physician-facing digital health infrastructure in the same geographies, and a potential distribution partner or competitive channel for physician adoption.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks7 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds5 records

Investors10 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Kranus Health